P-303: Dual burden: chemotherapy-induced diabetes in twin siblings with acute lymphoblastic leukemia in Nigeria: a case report
P-303: Doppelbelastung: durch Chemotherapie induzierter Diabetes bei Zwillingsgeschwistern mit akuter lymphoblastischer Leukämie in Nigeria: Fallbericht
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.361 ↗Auf einen Blick
Ein Fallbericht beschreibt CIDM bei Zwillingsgeschwistern mit ALL in Nigeria. Bei beiden trat unter der Therapie eine Hyperglykämie auf; nach Insulintherapie besserte sich die glykämische Kontrolle.
Fragestellung
Beschreibung der Entwicklung eines chemotherapy-induced diabetes mellitus (CIDM) bei Zwillingsgeschwistern mit ALL in Nigeria.
Methode
Fallbericht; beide Zwillinge erhielten dieselben Chemotherapieprotokolle mit hohen Dosen Glukokortikoiden und L-Asparaginase.
Ergebnisse
Nach 7 Tagen hatte der erste Zwilling Glycosurie, FBG 7,4 mmol/L und HbA1c 7,7 % (4–5,6 %). Die zweite Zwillingsschwester hatte zu Therapiebeginn Hyperglykämie, HbA1c 6,6 % und C-Peptid 392 pmol/L (260–1728).
Schlussfolgerung der Autor:innen
Aktives Screening auf möglichen CIDM verhindert eine verzögerte Diagnose und Behandlung und ist entscheidend, um lebensbedrohliche Komplikationen wie eine diabetische Ketoazidose zu vermeiden.
Kernaussagen
- CIDM trat bei beiden Zwillingen unter ALL-Therapie auf
- Insulintherapie und engmaschige Glukosekontrolle wurden eingesetzt
- Frühe Hyperglykämie-Erkennung ermöglichte Intervention vor DKA
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fallbericht in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von O Oladipo und 4 weiteren Autor:innen.
Themen: Onkologische Pflege, Diabetes mellitus
Abstract (Originalsprache)
Introduction
Chemotherapy-induced metabolic complications are increasingly recognized in paediatric oncology, yet the occurrence of chemotherapy-induced diabetes mellitus (CIDM) remains underreported, particularly in the paediatric population in low-resource settings.
Objectives
This case report describes the development of CIDM in a set of twins undergoing treatment for Acute Lymphoblastic Leukemia (ALL) in Nigeria, highlighting clinical presentation, management challenges, and implications for care. Methods - Results Case description: Twin siblings diagnosed with Leukemia were managed with the same chemotherapy protocols including high doses of glucocorticoids and L-asparaginase. Seven days into treatment, the first twin had generalized boils and poor intravenous site wound healing, urinalysis showed glycosuria and absent ketonuria, fasting blood glucose (FBG) was 7.4mmol/L, glycosylated haemoglobin A1c (HbA1c) showed diabetic levels of 7.7% (4 – 5.6%). About two years later, the second twin was also diagnosed with leukemia. She was screened at the commencement of therapy, she had hyperglycaemia, her HbA1C was 6.6% and C-peptide was 392 pmol/L (260 - 1728). There is a history of DM in their maternal grandma but neither of them had a prior history of diabetes and both of them had normal body mass index. Management involved insulin therapy with close glucose monitoring. The coexistence of ALL and CIDM posed significant challenges, including balancing glycemic control with the continuation of life-saving chemotherapy, as well as financial and psychosocial burdens on the family. However, early detection of hyperglycaemia presented an opportunity for intervention prior to the onset of DKA. Despite these challenges, both patients showed improvement in glycemic control and subsequent resolution of the CIDM with appropriate multidisciplinary care.
Conclusions
Active screening for possible CIDM prevents delayed diagnosis and management and is critical to averting life-threatening complications like diabetic ketoacidosis.
Zitieren
APA
Oladipo, O., Oyenusi, E., Fakile, U., Akinsete, A., & Oduwole, A. (2026). P-303: Dual burden: chemotherapy-induced diabetes in twin siblings with acute lymphoblastic leukemia in Nigeria: a case report. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.361
Vancouver
Oladipo O, Oyenusi E, Fakile U, Akinsete A, Oduwole A. P-303: Dual burden: chemotherapy-induced diabetes in twin siblings with acute lymphoblastic leukemia in Nigeria: a case report. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.361
BibTeX
@article{Oladipo2026,
author = {Oladipo, O and Oyenusi, E and Fakile, U and Akinsete, A and Oduwole, A},
title = {P-303: Dual burden: chemotherapy-induced diabetes in twin siblings with acute lymphoblastic leukemia in Nigeria: a case report},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.361}
}
EUVIMED